In Memoriam

Recently published articles about In Memoriam

JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on...
,
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
,
JCP
In Memoriam

January 4, 2022

Aaron T. Beck, founding father of Cognitive Therapy, was ranked the fourth most influential person in the history of medicine in a 2016 survey. Colleague and friend Michael Thase...
JCP
In Memoriam

October 13, 2020

S. Nassir Ghaemi reflects on the life and accomplishments of this founding pioneer of psychopharmacology.

Recent JCP Articles on In Memoriam

JCP
Prediction Of Adolescent Suicidal Events By Residual Depressive Symptoms
Original Research

May 21, 2025

Sleep disturbance and suicidal ideation were the strongest predictors of hospitalization, and, together with anhedonia, they consistently predicted suicidal events during follow-up.
, , , et al
JCP
Postpartum Distress in Women With and Without ADHD
Original Research

May 19, 2025

Women with ADHD were 1.14 times more likely to be diagnosed with mood disorder at 6 weeks postpartum and 1.21-1.24 times more likely to be diagnosed with a mood,...
, ,
JCP
Delirium as a Precursor to Dementia in Type 2 DM Patients
Original Research

May 19, 2025

Type 2 diabetes mellitus patients with delirium had a dementia incidence of 42.75%, compared to 22.66% in those without delirium, with a clear dose-response relationship of higher dementia risk...
, , , et al

Recent PCC Articles on In Memoriam

PCC
Prolonged Delirium After ECT
Case Report

May 20, 2025

The authors present a case of prolonged ECT-associated delirium in a 65-year-old woman, offering insights into the proposed pathophysiology.
, , , et al
PCC
Is It Munchausen or Is It Dementia?
Case Report

May 15, 2025

This case elucidates the diagnostic challenges associated with differentiating frontotemporal dementia from aggravating personality disorder or behavioral variant frontotemporal dementia.
, , , et al
PCC
Role of GLP-1 Receptor Agonists in AUD
Narrative Review

May 15, 2025

The authors examine the potential benefits, dosages, and mechanisms of GLP-1 receptor agonists on alcohol consumption and how they can potentially modify alcohol-seeking behavior.
, , , et al

Featured In Memoriam Research

Inside Rejoyn: A Breakthrough for Major Depression
news

May 20, 2025

Rejoyn is the first FDA-approved prescription digital therapeutic for major depressive disorder, designed to complement existing treatments.
Physical Comorbidities Drive Up Depression Risk
news

May 19, 2025

New research finds that people with multiple chronic physical conditions face a much higher risk of developing depression.
Could Mindfulness Crack Treatment-Resistant Depression?
news

May 16, 2025

New research shows that Mindfulness-Based Cognitive Therapy offers an effective and cost-saving option for difficult-to-treat depression.

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe